ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 152 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $201,000 | +37.7% | 3,875 | +25.2% | 0.00% | +50.0% |
| Q2 2022 | $146,000 | -21.9% | 3,095 | +17.7% | 0.00% | 0.0% |
| Q1 2022 | $187,000 | +1.6% | 2,629 | +6.9% | 0.00% | 0.0% |
| Q4 2021 | $184,000 | +35.3% | 2,459 | +2.5% | 0.00% | +100.0% |
| Q3 2021 | $136,000 | +21.4% | 2,399 | -6.1% | 0.00% | 0.0% |
| Q2 2021 | $112,000 | -5.1% | 2,556 | +6.6% | 0.00% | 0.0% |
| Q1 2021 | $118,000 | +25.5% | 2,398 | +7.4% | 0.00% | 0.0% |
| Q4 2020 | $94,000 | -5.1% | 2,232 | +3.6% | 0.00% | 0.0% |
| Q3 2020 | $99,000 | +147.5% | 2,154 | +170.9% | 0.00% | 0.0% |
| Q2 2020 | $40,000 | +11.1% | 795 | +13.9% | 0.00% | 0.0% |
| Q1 2020 | $36,000 | +2.9% | 698 | +23.3% | 0.00% | – |
| Q4 2019 | $35,000 | -2.8% | 566 | -4.9% | 0.00% | -100.0% |
| Q3 2019 | $36,000 | -25.0% | 595 | +4.0% | 0.00% | 0.0% |
| Q2 2019 | $48,000 | +11.6% | 572 | +27.1% | 0.00% | 0.0% |
| Q1 2019 | $43,000 | +53.6% | 450 | +15.4% | 0.00% | – |
| Q4 2018 | $28,000 | +7.7% | 390 | +30.4% | 0.00% | – |
| Q3 2018 | $26,000 | +333.3% | 299 | +464.2% | 0.00% | – |
| Q2 2018 | $6,000 | – | 53 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |